Melanie Lianne Engelfriet

Bilde av Melanie Lianne Engelfriet
English version of this page
Rom 2116
Brukernavn
Besøksadresse Blindernveien 31 0371 Oslo
Postadresse Postboks 1066 Blindern 0316 Oslo
Andre tilknytninger Det matematisk-naturvitenskapelige fakultet (Student)

Faglige interesser

I started my PhD in September 2019 in the research groups of Rafal Ciosk and Pål Falnes. During my PhD, I will characterize novel molecular mechanisms that regulate translation with an emphasis on the role of methyltransferases in translation. I am using the nematode C. elegans as an experimental model to elucidate how methylation of translation factors affects biological processes under various conditions. 

Bakgrunn

2019 - now   PhD at the department of Biosciences, University of Oslo, Norway. 

2016 - 2018  Master in Molecular Biology at the department of Biosciences, University of Oslo, Norway. 

2012 - 2016  Bachelor in Biology and Medical Laboratory Research at the department of Science and Technology, University of Applied Sciences Leiden, The Netherlands. 

Undervisning

BIOS2900 - Molekylærbiologi (TA)

BIOS4010 - Arbeidsmetoder i molekylærbiologi og biokjemi I (TA)

Priser

  • 2016: VSBfonds Scholarship. VSBfonds, NUFFIC, The Netherlands. Scholarship for Dutch students doing research abroad. 
  • 2015: KNCVTBC Grant. KNCV Tuberculosis Foundation, The Netherlands. Grant for Master and PhD students involved with scientific research on tuberculosis.

Publikasjoner

  • Engelfriet, Melanie Lianne; Malecki, Jedrzej Mieczyslaw; Forsberg, Frida; Falnes, Pål & Ciosk, Rafal (2023). Characterization of the biochemical activity and tumor-promoting role of the dual protein methyltransferase METL-13/METTL13 in Caenorhabditis elegans. PLOS ONE. ISSN 1932-6203. 18(6), s. 1–16. doi: 10.1371/journal.pone.0287558. Fulltekst i vitenarkiv
  • van der Schoot, Johan M. S.; Fenneman, Felix L.; Valente, Michael; Dolen, Yusuf; Hagemans, Iris M. & Becker, Anouk M. D. [Vis alle 21 forfattere av denne artikkelen] (2019). Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering. Science Advances. ISSN 2375-2548. 5(8). doi: 10.1126/sciadv.aaw1822.

Se alle arbeider i Cristin

Publisert 21. nov. 2019 09:21 - Sist endret 7. mai 2020 13:25

Forskergrupper